about
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of gale...
Read More
28.69
-0.22
(-0.76%)
231.4K
XNAS Volume
XNAS 09 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Galecto Inc is on 19 Mar 2026 for the purpose of Galecto Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Galecto Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..